|The benefits of Blue Light Cystoscopy in the detection of Bladder Cancer were explained in detail on Fox 11 News out of Los Angeles in a story that aired on January 20, 2020. The feature includes an interview with Dr. Sia Daneshmand. Watch now.|
Fox 11 News Los Angeles Features Blue Light Cystoscopy
Cysview® Nurse-User Presents Poster on BLC with Cysview Process
Rebecca B. Roe, MSN-Ed., RN, CNOR, Clinical Education Program Coordinator Surgical Services at Northside Hospital in Cumming, GA presented a poster at the SUNA National Meeting in Orlando in September 2019. UroToday.com interviewed this experienced Cysview user about her accomplishments.
In the video interview, Rebecca speaks to an interdisciplinary approach to implementation of Blue Light Cystoscopy (BLC™) in her community hospital center — giving a Clinical Education Program Coordinator’s perspective. Her team engaged in the five management practices looking at ongoing communication and clinical training and measured things along the way, seeking feedback from every discipline that was utilized, whether it be pharmacy, medical staff, nursing staff, communication, or leadership within the Surgical Services Departments.
Watch the feature entitled, Utilizing Change Management for Successful Implementation of Blue light cystoscopy (BLC™), on UroToday.com.
Experts on NMIBC publish consensus on Blue Light Cystoscopy with Cysview®
Read what an Expert Panel recommends for using Blue Light Cystoscopy with Cysview to treat non-muscle invasive bladder cancer. The Expert Consensus Document, published by Nature Reviews Urology, is entitled, Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statment on optimal use in the USA — update 2018. Read the paper.
Implementing Blue Light Flexible Cystoscopy in Non-muscle Invasive Bladder Cancer Surveillance
A review paper on Blue Light Cystoscopy (BLC™) with Hexvix®/Cysview® with focus on the use in the office setting with flexible cystoscopes was published on July 5, 2019, in the peer-reviewed European Medical Journal.
With emerging data confirming similar clinical benefits for flexible BLC in the surveillance of non-muscle invasive bladder cancer (NMIBC) to its current use in rigid cystoscopy, the authors state that there is a clear opportunity for flexible BLC to assert a central role in the treatment paradigm. In a clinical study, around 1 in 5 confirmed malignancies were detected only by flexible BLC (p<0.0001)1 and the introduction of flexible BLC for routine surveillance post-TURBT is supported by consensus among bladder cancer specialists2.
1 Daneshmand S et al. Efficacy and safety of blue light flexible cystoscopy with Hexaminolevulinate (HAL) in the surveillance of bladder cancer: A phase III, comparative, multi-center study. J Urol. 2018 Dec 2. pii: S0022-5347(17)78004-4. doi:10.1016/j.juro.2017.11.096.
2 Lotan Y, Bivalacqua TJ, Downs T, et al. Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA – Update 2018. Nat Rev Urol. 2019; pending. doi: 10.1038/s41585-019-0184-4. [Epub ahead of print].
Radio Interview Discusses Blue Light Cystoscopy
Upstate Medical University urologist Joseph Jacob, MD, took to the airwaves to explain how bladder tumors can be diagnosed using Blue Light Cystoscopy with Cysview in conjunction with traditional White Light Cystoscopy.
UConn Health Spotlights its BLC with Cysview Technology
UConn Health is promoting its use of Blue Light Cystoscopy with Cysview with an educational YouTube video. Watch it now.
Marcus Daly Memorial Hospital Features BLC with Cysview in its New State-of-the-Art Surgical Center
The Pacific Northwest now has Blue Light Cystoscopy with Cysview available in Hamilton, MT. Marcus Daly Memorial Hospital had the grand opening of its new state-of-the-art Surgical Center on Friday, April 26. This article, head of the surgery department, Dr. James J. Zubernis, discusses the importance of the technology being made available.
St. Mary Medical Center Announces Use of Blue Light Cystoscopy with Cysview
On April 25, 2019 KYW Newsradio ran a story about the availability of Blue Light Cystoscopy with Cysview at St. Mary Medical Center in Langhorne, PA. Read the story.
Survey of Bladder Cancer Patients Reveals Big Changes – Patients are Looking for Cysview® (hexaminolevulinate)
UroToday.com published the key results of a survey answered by 600 bladder cancer patients. The biggest take-aways were that, more than ever before, bladder cancer patients know about Blue Light Cystoscopy with Cysview and are selecting urologists and treatment facilities that offer it.